Patent · US Active

Use of alphavirus in preparation of antitumor drugs

US11235011B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Guangzhou Virotech Pharmaceutical Co., Ltd. · CN

Inventors

Guangmei Yan · 流花街道, CN
Xiao Xiao · Chapel Hill, US
Jun Hu · 流花街道, CN
Kai Li · Princeton, US
Jiankai LIANG · 流花街道, CN
Yuan Lin · 流花街道, CN
Haipeng ZHANG · 流花街道, CN
Suizhen Lin · 流花街道, CN

Key dates

Filing date	Nov 12, 2019
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Jan 27, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/36132
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is use of alphavirus in preparation of antitumor drugs. The alphavirus is M1 virus or Getah virus. In addition, the specific tumor types sensitive to abovementioned alphavirus treatment are further determined, so as to provide a safe and effective solution for antitumor drug administering schemes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.